LymphoSight: Quantifying Immune Contexture in Clinical Trials with Computational Pathology

• Explore how computational pathology can move beyond cell counting to quantify lymphocyte localisation, tumour-immune interactions and spatial organisation within the tumor microenvironment
• See how LymphoSight has been applied to paired H&E biopsies from a Phase III clinical study to investigate treatment-associated changes in immune contexture
• Learn how pathology-derived spatial features can be translated into interpretable evidence for pharmacodynamic assessment, response biology and biomarker development

Speakers:

Matthew Alderdice

Senior Vice President, Product

Sonrai Analytics